CR

CREEK & RIVER Co.,Ltd.

A creator agency connecting professionals in creative, tech, medical, and legal sectors.

4763 | T

Overview

Corporate Details

ISIN(s):
JP3269700005
LEI:
Country:
Japan
Address:
港区新橋四丁目1番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CREEK & RIVER Co., Ltd. is a multifaceted professional agency that pioneered the "creator agency" business model in Japan. The company specializes in connecting its extensive network of skilled professionals with businesses across various industries for staffing, outsourcing, and consulting projects. While its origins and strengths lie in creative fields—including video, games, web, and advertising—the firm has expanded its services to encompass a diverse range of professional sectors such as medicine, law, accounting, architecture, and advanced technology like AI and XR. In addition to its core agency business, CREEK & RIVER provides content production and rights management services, leveraging its diverse talent pool to drive innovation for its partners.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-10 05:17
Report Publication Announcement
確認書
Japanese 8.1 KB
2025-10-10 05:17
Interim Report
半期報告書-第36期(2025/03/01-2026/02/28)
Japanese 241.2 KB
2025-06-02 09:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-05-30 08:22
Post-Annual General Meeting Information
臨時報告書
Japanese 26.5 KB
2025-05-30 08:21
Governance Information
内部統制報告書-第35期(2024/03/01-2025/02/28)
Japanese 22.4 KB
2025-05-30 08:20
Registration Form
確認書
Japanese 8.2 KB
2025-05-30 08:19
Annual Report
有価証券報告書-第35期(2024/03/01-2025/02/28)
Japanese 2.9 MB
2025-05-01 09:13
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-04-01 09:27
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-03-21 07:58
Regulatory News Service
臨時報告書
Japanese 28.6 KB
2025-03-04 03:46
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2025-02-03 07:47
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 20.9 KB
2024-12-02 02:03
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.0 KB
2024-11-06 01:53
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 21.1 KB
2024-10-11 03:52
Interim Report
半期報告書-第35期(2024/03/01-2025/02/28)
Japanese 254.6 KB

Automate Your Workflow. Get a real-time feed of all CREEK & RIVER Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CREEK & RIVER Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CREEK & RIVER Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Bestone.Com Co.,Ltd Logo
An online travel agency specializing in domestic and overseas cruise tours and tickets.
Japan
6577
BeyondSpring Inc. Logo
Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.
United States of America
BYSI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.
United States of America
BIAF
BIO-FD&C CO.,LTD. Logo
Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.
South Korea
251120
BioNexus Gene Lab Corp Logo
Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.
France
ALBPS
BioSenic SA Logo
Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.
Belgium
BIOS
BIOTECH Logo
Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.
Spain
BST
BiotoxtechCo.,Ltd. Logo
A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.
South Korea
086040
Bolt Biotherapeutics, Inc. Logo
Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.
United States of America
BOLT

Talk to a Data Expert

Have a question? We'll get back to you promptly.